Medication info
Mirtel Plus Tablet 80/12.5 mg

Mirtel Plus Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Samcheondang Pharmaceutical Co., Ltd.
Appearance
White or almost white, biconvex round tablets
Packaging
30 tablets/box [(10 tablets/PTP)x3]
Approval status
Active

MFDS item code 201701099 · Approved 2017.02.28 · Insurance code 651204990

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan monotherapy, take this medicine once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately according to the patient's needs. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg plus hydrochlorothiazide 12.5mg as separate products or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance <30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Use this medicine with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine once daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be used with caution in patients with impaired liver function. Older adults No dose adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Samcheondang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is mainly used for patients with essential hypertension. It helps effectively control blood pressure when blood pressure is not adequately managed with monotherapy. Therefore, it is recommended as an appropriate treatment option for those who have difficulty managing their blood pressure.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan monotherapy, take this medicine once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately according to the patient's needs. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg plus hydrochlorothiazide 12.5mg as separate products or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance <30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Use this medicine with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine once daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be used with caution in patients with impaired liver function. Older adults No dose adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause severe harm to the fetus. If pregnancy is confirmed, the use of this medication should be stopped immediately, and alternative treatments should be considered. Patients who are allergic to any component or additive of this medication, pregnant women, nursing mothers, and patients with severe liver or kidney disease should not be administered this medication. Additionally, patients with obstructive biliary disease or bile stasis should not use this medication. Elderly patients, patients with impaired liver function, and patients with cardiovascular disease should be administered with caution, ensuring that blood pressure does not drop too low. The Hydrochlorothiazide component can affect electrolyte balance in the body, which may lead to electrolyte abnormalities such as hypokalemia or hyperkalemia, so regular blood tests are necessary. During the use of this medication, the risk of skin cancer may increase, so exposure to sunlight should be avoided, and any skin abnormalities should be reported to a physician immediately. Symptoms such as severe dizziness, hypotension, and arrhythmias may occur, so immediate consultation with medical personnel is necessary if these symptoms arise. Due to numerous drug interactions, it is important to inform healthcare professionals of any other medications being taken, especially caution is required when taking with lithium, potassium supplements, diuretics, and antihypertensive medications. This medication may cause drowsiness or dizziness when driving or operating machinery, so caution is required during these activities. In case of overdose, the risks of hypotension, electrolyte imbalance, and dehydration exist; therefore, the prescribed dosage must be strictly followed, and in case of abnormal symptoms, healthcare facilities should be visited immediately. Safety and efficacy have not been established for children and adolescents under 18 years of age.

Side effects

  • Hypotension
  • neonatal craniosynostosis
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb dyskinesia
  • craniofacial malformation
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 130 more
  • patent ductus arteriosus
  • bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disturbances
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver function abnormality
  • liver dysfunction
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • elevated blood uric acid
  • increased serum creatinine
  • increased serum creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic epidermal necrolysis
  • pain in the bones
  • renal impairment
  • weakness
  • reduced hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • aplastic anemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • headache
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal exudate
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal impairment
  • weakness
  • fever
  • dizziness
  • itching
  • myalgia
  • feeling of floating
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • fatigue
  • weight loss
  • proteinuria
  • headache
  • tremors of the lips and hands
  • hypersensitivity
  • gum disease
  • dry lips
  • visual impairment
  • hypoglycemia
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. This helps in maintaining the efficacy of the medication for a longer duration.

Appearance and packaging

Appearance

White or almost white, biconvex round tablets

Package unit

30 tablets/box [(10 tablets/PTP)x3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.